These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15258447)

  • 41. A comparative study of leukaemia inhibitory factor and interleukin-1alpha intracellular content in a human keratinocyte cell line after exposure to cosmetic fragrances and sodium dodecyl sulphate.
    Parodi A; Sanguineti R; Catalano M; Penco S; Pronzato MA; Scanarotti C; Bassi AM
    Toxicol Lett; 2010 Feb; 192(2):101-7. PubMed ID: 19878710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Bovine udder skin (BUS): testing of skin compatibility and skin protection].
    Pittermann WF; Kietzmann M
    ALTEX; 2006; 23(2):65-71. PubMed ID: 16688383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Moisturizing lotions can increase transdermal absorption of the herbicide 2,4-dichlorophenoxacetic acid across hairless mouse skin.
    Brand RM; Charron AR; Sandler VL; Jendrzejewski JL
    Cutan Ocul Toxicol; 2007; 26(1):15-23. PubMed ID: 17464745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Artificial reduction in transepidermal water loss improves skin barrier function.
    Buraczewska I; Broström U; Lodén M
    Br J Dermatol; 2007 Jul; 157(1):82-6. PubMed ID: 17553058
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Aqueous Cream BP on human stratum corneum in vivo.
    Tsang M; Guy RH
    Br J Dermatol; 2010 Nov; 163(5):954-8. PubMed ID: 20649794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of adipose differentiation related protein and neutral lipid droplet accumulation in keratinocytes by skin irritants.
    Corsini E; Viviani B; Zancanella O; Lucchi L; Visioli F; Serrero G; Bartesaghi S; Galli CL; Marinovich M
    J Invest Dermatol; 2003 Aug; 121(2):337-44. PubMed ID: 12880426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variation in barrier impairment and inflammation of human skin as determined by sodium lauryl sulphate penetration rate.
    de Jongh CM; Jakasa I; Verberk MM; Kezic S
    Br J Dermatol; 2006 Apr; 154(4):651-7. PubMed ID: 16536807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human scalp irritation compared to that of the arm and back.
    Zhai H; Fautz R; Fuchs A; Bhandarkar S; Maibach HI
    Contact Dermatitis; 2004 Oct; 51(4):196-200. PubMed ID: 15500669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-occlusive topical exposure of human skin in vitro as model for cytotoxicity testing of irritant compounds.
    Lönnqvist S; Briheim K; Kratz G
    Toxicol Mech Methods; 2016 Feb; 26(2):82-7. PubMed ID: 26446981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of barrier creams against sulphur mustard: (II) In vivo and in vitro studies using the domestic white pig.
    Chilcott RP; Dalton CH; Ashley Z; Allen CE; Bradley ST; Maidment MP; Jenner J; Brown RF; Gwyther RJ; Rice P
    Cutan Ocul Toxicol; 2007; 26(3):235-47. PubMed ID: 17687688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of different cosmetic formulations on the human skin barrier.
    Heinrich K; Heinrich U; Tronnier H
    Skin Pharmacol Physiol; 2014; 27(3):141-7. PubMed ID: 24434680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experimentally induced chronic irritant contact dermatitis to evaluate the efficacy of protective creams in vivo.
    Wigger-Alberti W; Caduff L; Burg G; Elsner P
    J Am Acad Dermatol; 1999 Apr; 40(4):590-6. PubMed ID: 10188679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulating effects of oatmeal extracts in the sodium lauryl sulfate skin irritancy model.
    Vié K; Cours-Darne S; Vienne MP; Boyer F; Fabre B; Dupuy P
    Skin Pharmacol Appl Skin Physiol; 2002; 15(2):120-4. PubMed ID: 11867969
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Skin protection against ionized cobalt and sodium lauryl sulphate with barrier creams.
    Fischer T; Rystedt I
    Contact Dermatitis; 1983 Mar; 9(2):125-30. PubMed ID: 6221864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Examples of the use of cell cultures in skin irritancy assessment.
    Rougier A
    Curr Probl Dermatol; 1995; 22():214-30. PubMed ID: 7587327
    [No Abstract]   [Full Text] [Related]  

  • 56. Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin.
    Fang JY; Hung CF; Chiu HC; Wang JJ; Chan TF
    J Pharm Pharmacol; 2003 Aug; 55(8):1175. PubMed ID: 12956910
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of barrier creams: an in vitro technique on human skin.
    Treffel P; Gabard B; Juch R
    Acta Derm Venereol; 1994 Jan; 74(1):7-11. PubMed ID: 7511868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimisation of a dosing regime for a topical skin protectant (barrier cream).
    Chilcott RP; Larner J; Matar H; Kansagra S; Theivendran B; Viegas VA; Goldman VS
    Cutan Ocul Toxicol; 2015; 34(4):327-34. PubMed ID: 25597377
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human Induced Pluripotent Stem Cell-Based Skin for Assessing Transdermal Drug Permeability and Irritancy.
    Naito C; Yamaguchi T; Katsumi H; Kimura S; Kamei S; Morishita M; Kawabata K; Yamamoto A
    Biol Pharm Bull; 2021; 44(1):140-143. PubMed ID: 33390542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Skin-identical lipids versus petrolatum in the treatment of tape-stripped and detergent-perturbed human skin.
    Lodén M; Bárány E
    Acta Derm Venereol; 2000; 80(6):412-5. PubMed ID: 11243632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.